Pub Date : 2025-10-20DOI: 10.1016/j.jchromb.2025.124831
Zhikun Li, Yuanyuan Li, Yulong Ma, Wenxin Ji, Yonggang Sun
The purification of biomacromolecules, particularly proteins, plays an increasingly vital role in the fields of medicine, biopharmaceuticals, and emerging technologies. Adsorbents with excellent adsorption capacity, superior cycling performance, and environmental compatibility are crucial for protein separation and adsorption. A temperature- and pH dual-stimulus responsive hydrogel material for the adsorption and separation of protein was successfully prepared by copolymerizing sodium alginate (SA) as the matrix with N-isopropylacrylamide (NIPAM), acrylic acid (AAC), and simultaneously introducing zirconium-based metal-organic frameworks (Zr-MOF). This hydrogel material exhibits excellent adsorption and controlled release properties for protein including bovine hemoglobin (BHB) and bovine serum albumin (BSA) with maximum adsorption capacities of 617.45 mg/g and 527.06 mg/g at 45 °C, respectively. Experimental results demonstrate that the adsorption and release behavior of the hydrogel toward proteins can be effectively regulated by adjusting environmental temperature or pH value in an aqueous medium without any acidic, alkaline, high-salt, or organic solvent. Additionally, the material exhibits good cyclic stability, maintaining more than 85 % of its initial protein adsorption capacity after five adsorption-desorption cycles. This study provides new insights into the development of smart responsive biomolecular adsorption materials and has significant application potential in the fields such as drug controlled release and biological separation.
{"title":"Preparation of sodium alginate-based temperature- and pH-responsive MOF/hydrogel microspheres and their adsorption and separation of proteins","authors":"Zhikun Li, Yuanyuan Li, Yulong Ma, Wenxin Ji, Yonggang Sun","doi":"10.1016/j.jchromb.2025.124831","DOIUrl":"10.1016/j.jchromb.2025.124831","url":null,"abstract":"<div><div>The purification of biomacromolecules, particularly proteins, plays an increasingly vital role in the fields of medicine, biopharmaceuticals, and emerging technologies. Adsorbents with excellent adsorption capacity, superior cycling performance, and environmental compatibility are crucial for protein separation and adsorption. A temperature- and pH dual-stimulus responsive hydrogel material for the adsorption and separation of protein was successfully prepared by copolymerizing sodium alginate (SA) as the matrix with N-isopropylacrylamide (NIPAM), acrylic acid (AAC), and simultaneously introducing zirconium-based metal-organic frameworks (Zr-MOF). This hydrogel material exhibits excellent adsorption and controlled release properties for protein including bovine hemoglobin (BHB) and bovine serum albumin (BSA) with maximum adsorption capacities of 617.45 mg/g and 527.06 mg/g at 45 °C, respectively. Experimental results demonstrate that the adsorption and release behavior of the hydrogel toward proteins can be effectively regulated by adjusting environmental temperature or pH value in an aqueous medium without any acidic, alkaline, high-salt, or organic solvent. Additionally, the material exhibits good cyclic stability, maintaining more than 85 % of its initial protein adsorption capacity after five adsorption-desorption cycles. This study provides new insights into the development of smart responsive biomolecular adsorption materials and has significant application potential in the fields such as drug controlled release and biological separation.</div></div>","PeriodicalId":348,"journal":{"name":"Journal of Chromatography B","volume":"1267 ","pages":"Article 124831"},"PeriodicalIF":2.8,"publicationDate":"2025-10-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145351441","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-15DOI: 10.1016/j.jchromb.2025.124823
Weiwei Wu , Jingjing Song , Qiuyue Wu , Xin Wu , Ning Sun , Xinyi Xia
Metagenomic next-generation sequencing (mNGS) enables unbiased detection of human pathogens without prior assumptions. However, the direct detection of bloodstream infection pathogens is limited by host DNA interference, leading to the clinical adoption of microbial cell-free DNA mNGS (plasma cfDNA mNGS). This study developed a host cell depletion method based on immunomagnetic separation using CD45-conjugated magnetic particles (CD45-MPs, termed the IP method) to reduce host DNA interference and enhance mNGS performance for bloodstream pathogen detection. In simulated samples, known concentrations of pathogens (intact Escherichia coli and Candida albicans cells, fragmented Staphylococcus aureus genomic DNA) were spiked into whole blood samples, serially diluted 10-fold, and divided into whole blood, plasma, and IP-treated groups. These groups were analyzed using hematological analysis, microscopic smear, DNA concentration measurement, relative quantification of GAPDH using qPCR, and mNGS. Results showed that CD45-conjugated magnetic particles effectively removed host cells from whole blood (reducing cell count by 99.9%). The results of nucleic acid measurement and qPCR indicated that the supernatant from IP-treated samples contained significantly lower host DNA compared to whole blood and plasma groups. mNGS detection of simulated samples demonstrated that the IP method enabled detection of pathogens at concentrations as low as 100 CFU/mL for E. coli and S. aureus, and 50 CFU/mL for C. albicans. In clinical testing of 77 samples from patients with suspected bloodstream infections, mNGS combined with the IP method showed significantly higher positivity rates than plasma cfDNA mNGS. In conclusion, CD45-conjugated magnetic particles effectively deplete human cells and enhance the clinical performance of mNGS on the detection of bloodstream infections.
{"title":"Development and evaluation of CD45-conjugated magnetic particles-based host cell depletion for enhanced metagenomic next-generation sequencing in bloodstream infection","authors":"Weiwei Wu , Jingjing Song , Qiuyue Wu , Xin Wu , Ning Sun , Xinyi Xia","doi":"10.1016/j.jchromb.2025.124823","DOIUrl":"10.1016/j.jchromb.2025.124823","url":null,"abstract":"<div><div>Metagenomic next-generation sequencing (mNGS) enables unbiased detection of human pathogens without prior assumptions. However, the direct detection of bloodstream infection pathogens is limited by host DNA interference, leading to the clinical adoption of microbial cell-free DNA mNGS (plasma cfDNA mNGS). This study developed a host cell depletion method based on immunomagnetic separation using CD45-conjugated magnetic particles (CD45-MPs, termed the IP method) to reduce host DNA interference and enhance mNGS performance for bloodstream pathogen detection. In simulated samples, known concentrations of pathogens (intact <em>Escherichia coli</em> and <em>Candida albicans</em> cells, fragmented <em>Staphylococcus aureus</em> genomic DNA) were spiked into whole blood samples, serially diluted 10-fold, and divided into whole blood, plasma, and IP-treated groups. These groups were analyzed using hematological analysis, microscopic smear, DNA concentration measurement, relative quantification of GAPDH using qPCR, and mNGS. Results showed that CD45-conjugated magnetic particles effectively removed host cells from whole blood (reducing cell count by 99.9%). The results of nucleic acid measurement and qPCR indicated that the supernatant from IP-treated samples contained significantly lower host DNA compared to whole blood and plasma groups. mNGS detection of simulated samples demonstrated that the IP method enabled detection of pathogens at concentrations as low as 100 CFU/mL for <em>E. coli</em> and <em>S. aureus</em>, and 50 CFU/mL for <em>C. albicans</em>. In clinical testing of 77 samples from patients with suspected bloodstream infections, mNGS combined with the IP method showed significantly higher positivity rates than plasma cfDNA mNGS. In conclusion, CD45-conjugated magnetic particles effectively deplete human cells and enhance the clinical performance of mNGS on the detection of bloodstream infections.</div></div>","PeriodicalId":348,"journal":{"name":"Journal of Chromatography B","volume":"1267 ","pages":"Article 124823"},"PeriodicalIF":2.8,"publicationDate":"2025-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145319093","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-15DOI: 10.1016/j.jchromb.2025.124824
Farah Hudaib , Sanaa Bardaweel , Wesam Darwish , Salah Abdelrazig , Lina A. Dahabiyeh
Colorectal cancer (CRC) remains one of the leading causes of cancer-related mortality worldwide. Current treatments are often limited by multidrug resistance and significant side effects, underscoring the urgent need for novel therapeutic strategies. Leukotriene receptor antagonists (LTRAs), including montelukast, zafirlukast, and pranlukast, have shown promising anticancer potential; however, their underlying molecular mechanisms remain insufficiently understood. In this study, the antiproliferative effects of montelukast, zafirlukast, and pranlukast on CRC cell lines (HCT-116 and Caco-2) were evaluated using cell viability and proliferation assays. Montelukast and zafirlukast were further examined using a liquid chromatography-mass spectrometry (LC-MS)-based metabolomics to assess any possible metabolic alterations in HCT-116 cells, along with flow cytometry to determine their effects on cell death. Montelukast and zafirlukast were found to significantly inhibit the cell proliferation of HCT-116 in a dose-dependent manner, with IC₅₀ values of 57.4 μM and 73.28 μM, respectively. Flow cytometry demonstrated that apoptosis was the predominant mode of cell death with both drugs. Neither montelukast nor zafirlukast showed any significant in vitro antioxidant effects. LC-MS Metabolomics revealed that montelukast and zafirlukast induced distinct metabolic changes with 47 and 34 significantly altered metabolites, respectively. Montelukast notably affected mannosamine, 5-oxo-L-proline, acetyl-phenylalanine, acetoin, and taurine, implicating pathways related to amino acid metabolism, redox homeostasis, and mitochondrial function. In contrast, zafirlukast impacted nucleotide-related metabolites, including inosine, adenine, cytidine, deoxyguanosine, and itaconate, highlighting nucleotide biosynthesis and immunometabolism disruptions. These findings demonstrate the antiproliferative potential of montelukast and zafirlukast in CRC and provide new insights into their distinct molecular mechanisms of action. This supports their potential repurposing as adjunctive therapies in CRC treatment.
{"title":"LC-MS-based metabolomics revealed promising role of leukotriene receptor antagonists against colorectal cancer","authors":"Farah Hudaib , Sanaa Bardaweel , Wesam Darwish , Salah Abdelrazig , Lina A. Dahabiyeh","doi":"10.1016/j.jchromb.2025.124824","DOIUrl":"10.1016/j.jchromb.2025.124824","url":null,"abstract":"<div><div>Colorectal cancer (CRC) remains one of the leading causes of cancer-related mortality worldwide. Current treatments are often limited by multidrug resistance and significant side effects, underscoring the urgent need for novel therapeutic strategies. Leukotriene receptor antagonists (LTRAs), including montelukast, zafirlukast, and pranlukast, have shown promising anticancer potential; however, their underlying molecular mechanisms remain insufficiently understood. In this study, the antiproliferative effects of montelukast, zafirlukast, and pranlukast on CRC cell lines (HCT-116 and Caco-2) were evaluated using cell viability and proliferation assays. Montelukast and zafirlukast were further examined using a liquid chromatography-mass spectrometry (LC-MS)-based metabolomics to assess any possible metabolic alterations in HCT-116 cells, along with flow cytometry to determine their effects on cell death. Montelukast and zafirlukast were found to significantly inhibit the cell proliferation of HCT-116 in a dose-dependent manner, with IC₅₀ values of 57.4 μM and 73.28 μM, respectively. Flow cytometry demonstrated that apoptosis was the predominant mode of cell death with both drugs. Neither montelukast nor zafirlukast showed any significant in vitro antioxidant effects. LC-MS Metabolomics revealed that montelukast and zafirlukast induced distinct metabolic changes with 47 and 34 significantly altered metabolites, respectively. Montelukast notably affected mannosamine, 5-oxo-L-proline, acetyl-phenylalanine, acetoin, and taurine, implicating pathways related to amino acid metabolism, redox homeostasis, and mitochondrial function. In contrast, zafirlukast impacted nucleotide-related metabolites, including inosine, adenine, cytidine, deoxyguanosine, and itaconate, highlighting nucleotide biosynthesis and immunometabolism disruptions. These findings demonstrate the antiproliferative potential of montelukast and zafirlukast in CRC and provide new insights into their distinct molecular mechanisms of action. This supports their potential repurposing as adjunctive therapies in CRC treatment.</div></div>","PeriodicalId":348,"journal":{"name":"Journal of Chromatography B","volume":"1267 ","pages":"Article 124824"},"PeriodicalIF":2.8,"publicationDate":"2025-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145319060","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-12DOI: 10.1016/j.jchromb.2025.124822
Zhi-Peng Li , Chen-Ri Su , Long-Xin Yang , Han-Yue Li , Han Zhang , Ji-Fei Yang , Xian-Hua Wang , Yun-Chao Liu , Rui-Xue Ran
Glucocorticoids play a key role in a variety of physiological processes, but their extensive use in the environment has brought potential health hazards. Herein, it is of great necessity to develop a rapid and efficient method for the detection of glucocorticoids. In this work, a hydrophilic core-shell structured magnetic covalent organic framework (HMCOF) was fabricated via a post-modification strategy for the efficient magnetic solid-phase extraction (MSPE) of five glucocorticoids from tap water and milk samples. The HMCOF featured a Fe₃O₄@SiO₂ magnetic core encapsulated by a porous COF shell modified with polyethylene glycol, endowing it with a hydrophilic outer layer, porous structure and sufficient paramagnetism. The adsorption studies showed that HMCOF exhibited high adsorption capacities (50.77–80.25 mg g−1) for glucocorticoids. Notably, HMCOF retained 80 % of its adsorption capacity after 5 cycles, confirming its reusability. Under the optimal conditions of MSPE, the HMCOF-based MSPE-UPLC method was developed to test five glucocorticoids, which demonstrated good linearity (5–150 ng mL−1, R2 ≥ 0.9991), low detection limits (0.2–1.4 ng mL−1) and satisfactory spiked recovery rates (89.5–114.2 %) with intra-day variability below 4.3 % and inter-day precision within 6.3 %. The method underscores the potential of HMCOF serving as an adsorbent for MSPE, providing a promising approach for the analysis of glucocorticoids within food products.
糖皮质激素在多种生理过程中发挥着关键作用,但其在环境中的广泛使用带来了潜在的健康危害。因此,开发一种快速有效的糖皮质激素检测方法是十分必要的。在这项工作中,通过后修饰策略制备了亲水性核壳结构磁性共价有机骨架(HMCOF),用于从自来水和牛奶样品中高效地提取五种糖皮质激素。HMCOF的特点是Fe₃O₄@SiO₂磁芯被聚乙二醇修饰的多孔COF壳包裹,使其具有亲水性外层、多孔结构和足够的顺磁性。吸附研究表明,HMCOF对糖皮质激素具有较高的吸附量(50.77 ~ 80.25 mg g-1)。值得注意的是,HMCOF在5次循环后仍保持了80%的吸附容量,证实了其可重复使用。在最佳MSPE条件下,建立了基于hmcof的MSPE- uplc检测5种糖皮质激素的方法,线性良好(5 ~ 150 ng mL-1, R2≥0.9991),检出限低(0.2 ~ 1.4 ng mL-1),加标回收率(89.5 ~ 114.2%),日内变异性小于4.3%,日内精密度在6.3%以内。该方法强调了HMCOF作为MSPE吸附剂的潜力,为食品中糖皮质激素的分析提供了一种有前途的方法。
{"title":"Facile construction of hydrophilic core-shell structured magnetic covalent organic framework for efficient magnetic solid-phase extraction of five glucocorticoids from milk sample","authors":"Zhi-Peng Li , Chen-Ri Su , Long-Xin Yang , Han-Yue Li , Han Zhang , Ji-Fei Yang , Xian-Hua Wang , Yun-Chao Liu , Rui-Xue Ran","doi":"10.1016/j.jchromb.2025.124822","DOIUrl":"10.1016/j.jchromb.2025.124822","url":null,"abstract":"<div><div>Glucocorticoids play a key role in a variety of physiological processes, but their extensive use in the environment has brought potential health hazards. Herein, it is of great necessity to develop a rapid and efficient method for the detection of glucocorticoids. In this work, a hydrophilic core-shell structured magnetic covalent organic framework (HMCOF) was fabricated via a post-modification strategy for the efficient magnetic solid-phase extraction (MSPE) of five glucocorticoids from tap water and milk samples. The HMCOF featured a Fe₃O₄@SiO₂ magnetic core encapsulated by a porous COF shell modified with polyethylene glycol, endowing it with a hydrophilic outer layer, porous structure and sufficient paramagnetism. The adsorption studies showed that HMCOF exhibited high adsorption capacities (50.77–80.25 mg g<sup>−1</sup>) for glucocorticoids. Notably, HMCOF retained 80 % of its adsorption capacity after 5 cycles, confirming its reusability. Under the optimal conditions of MSPE, the HMCOF-based MSPE-UPLC method was developed to test five glucocorticoids, which demonstrated good linearity (5–150 ng mL<sup>−1</sup>, R<sup>2</sup> ≥ 0.9991), low detection limits (0.2–1.4 ng mL<sup>−1</sup>) and satisfactory spiked recovery rates (89.5–114.2 %) with intra-day variability below 4.3 % and inter-day precision within 6.3 %. The method underscores the potential of HMCOF serving as an adsorbent for MSPE, providing a promising approach for the analysis of glucocorticoids within food products.</div></div>","PeriodicalId":348,"journal":{"name":"Journal of Chromatography B","volume":"1267 ","pages":"Article 124822"},"PeriodicalIF":2.8,"publicationDate":"2025-10-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145305269","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-10DOI: 10.1016/j.jchromb.2025.124813
Liwen Liang , Yunlong Guo , Xu Yao , Guangzhi Cai , Xiaokang Liu , Jiyu Gong
Diabetes Mellitus (DM) represents a significant global health challenge, necessitating the development of novel therapeutic agents with reduced adverse effects for effective management. This study investigated the hypoglycemic potential of total saponins derived from American ginseng (TSAG), focusing on its inhibitory activity against α-amylase and its modulatory effects on insulin resistance in HepG2 cells. Results from the α-amylase inhibition assay demonstrated that TSAG elicited significant, concentration-dependent inhibition. Enzyme kinetic analysis revealed that TSAG functions as a reversible, mixed-type inhibitor of α-amylase. In insulin-resistant HepG2 cells, TSAG significantly enhanced glucose consumption and promoted glycogen synthesis, indicating its capacity to ameliorate insulin sensitivity. Ultra-high-performance liquid chromatography coupled with quadrupole orbitrap mass spectrometry (UHPLC-Q-Orbitrap/MS) analysis identified 40 ginsenoside constituents within TSAG. Molecular docking studies demonstrated high-affinity binding interactions between these key ginsenosides and α-amylase, corroborating their contribution to the observed inhibitory effects. Collectively, these findings highlight the therapeutic potential of American ginseng saponins in diabetes management, particularly in improving postprandial glycemic control and enhancing insulin sensitivity.
{"title":"Hypoglycemic potential of American ginseng saponins: inhibition of α-amylase and improvement of insulin resistance","authors":"Liwen Liang , Yunlong Guo , Xu Yao , Guangzhi Cai , Xiaokang Liu , Jiyu Gong","doi":"10.1016/j.jchromb.2025.124813","DOIUrl":"10.1016/j.jchromb.2025.124813","url":null,"abstract":"<div><div>Diabetes Mellitus (DM) represents a significant global health challenge, necessitating the development of novel therapeutic agents with reduced adverse effects for effective management. This study investigated the hypoglycemic potential of total saponins derived from American <em>ginseng</em> (TSAG), focusing on its inhibitory activity against α-amylase and its modulatory effects on insulin resistance in HepG2 cells. Results from the α-amylase inhibition assay demonstrated that TSAG elicited significant, concentration-dependent inhibition. Enzyme kinetic analysis revealed that TSAG functions as a reversible, mixed-type inhibitor of α-amylase. In insulin-resistant HepG2 cells, TSAG significantly enhanced glucose consumption and promoted glycogen synthesis, indicating its capacity to ameliorate insulin sensitivity. Ultra-high-performance liquid chromatography coupled with quadrupole orbitrap mass spectrometry (UHPLC-Q-Orbitrap/MS) analysis identified 40 ginsenoside constituents within TSAG. Molecular docking studies demonstrated high-affinity binding interactions between these key ginsenosides and α-amylase, corroborating their contribution to the observed inhibitory effects. Collectively, these findings highlight the therapeutic potential of American <em>ginseng</em> saponins in diabetes management, particularly in improving postprandial glycemic control and enhancing insulin sensitivity.</div></div>","PeriodicalId":348,"journal":{"name":"Journal of Chromatography B","volume":"1267 ","pages":"Article 124813"},"PeriodicalIF":2.8,"publicationDate":"2025-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145282470","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-08DOI: 10.1016/j.jchromb.2025.124814
Subhash Kumar , Virender Kumar , Dharam Singh
L-asparaginase (L-ASNase) is used to treat acute lymphoblastic leukemia and acrylamide reduction in food. Presently, recombinant L-ASNase formulations are produced in the cytoplasmic fractions of E. coli. Here, we describe an efficient approach for secretory expression of recombinant L-ASNase II (Pg-ASNase II) with pelB signal peptide in the E. coli expression host. Pg-asn II was successfully cloned and expressed in pET-26b(+) having pelB leader sequence for periplasmic expression. It led to the successful secretion of Pg-ASNase II in the supernatant. However, a significant amount of Pg-ASNase II was also left in the cytoplasmic space. The protein secretion increased from 0.33 to 0.77 mg mL-1 with 0.2 % Tween 80 in the medium. Pg-ASNase II was purified in a single chromatographic step using a Q-sepharose column with 8.0 mg L−1 purified protein production and 60.0 U mg-1Pg-ASNase II activity. It demonstrated a 75 % yield and a 15-fold increase in purification. The current study reported an increased extracellular L-ASNase expression compared to the wild organism and helped reduce the cost of the downstream process. Hence, this research can contribute to upcoming investigations of periplasmic Pg-ASNase II for therapeutic applications.
l -天冬酰胺酶(L-ASNase)用于治疗急性淋巴细胞白血病和减少食物中的丙烯酰胺。目前,重组L-ASNase制剂是在大肠杆菌的细胞质部分中生产的。在此,我们描述了一种在大肠杆菌表达宿主中分泌表达含有pelB信号肽的重组L-ASNase II (Pg-ASNase II)的有效方法。成功克隆出Pg-asn II,并在pET-26b(+)中表达,具有pelB领导序列,可在质周表达。这导致Pg-ASNase II在上清液中成功分泌。然而,大量的Pg-ASNase II也留在细胞质间隙中。当培养基中添加0.2%的Tween 80时,蛋白质分泌量从0.33 mg mL-1增加到0.77 mg mL-1。Pg-ASNase II采用Q-sepharose柱纯化,纯化蛋白产量为8.0 mg L-1,活性为60.0 U mg- 1pg - asnase II。它证明了75%的产量和15倍的净化。目前的研究报告了与野生生物相比,细胞外L-ASNase表达增加,有助于降低下游过程的成本。因此,本研究可以为即将开展的质周Pg-ASNase II的治疗应用研究做出贡献。
{"title":"Secretory expression and optimization of type II L-asparaginase from Pseudomonas sp. PCH199","authors":"Subhash Kumar , Virender Kumar , Dharam Singh","doi":"10.1016/j.jchromb.2025.124814","DOIUrl":"10.1016/j.jchromb.2025.124814","url":null,"abstract":"<div><div>L-asparaginase (L-ASNase) is used to treat acute lymphoblastic leukemia and acrylamide reduction in food. Presently, recombinant L-ASNase formulations are produced in the cytoplasmic fractions of <em>E. coli</em>. Here, we describe an efficient approach for secretory expression of recombinant L-ASNase II (<em>Pg</em>-ASNase II) with pelB signal peptide in the <em>E. coli</em> expression host. <em>Pg-asn</em> II was successfully cloned and expressed in pET-26b(+) having pelB leader sequence for periplasmic expression. It led to the successful secretion of <em>Pg</em>-ASNase II in the supernatant. However, a significant amount of <em>Pg</em>-ASNase II was also left in the cytoplasmic space. The protein secretion increased from 0.33 to 0.77 mg mL<sup>-1</sup> with 0.2 % Tween 80 in the medium. <em>Pg</em>-ASNase II was purified in a single chromatographic step using a Q-sepharose column with 8.0 mg L<sup>−1</sup> purified protein production and 60.0 U mg<sup>-1</sup> <em>Pg</em>-ASNase II activity. It demonstrated a 75 % yield and a 15-fold increase in purification. The current study reported an increased extracellular L-ASNase expression compared to the wild organism and helped reduce the cost of the downstream process. Hence, this research can contribute to upcoming investigations of periplasmic <em>Pg</em>-ASNase II for therapeutic applications.</div></div>","PeriodicalId":348,"journal":{"name":"Journal of Chromatography B","volume":"1267 ","pages":"Article 124814"},"PeriodicalIF":2.8,"publicationDate":"2025-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145305272","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Epitope tag–monoclonal antibody (mAb) systems are essential tools in biotechnology. We developed a novel system based on the mGMOP peptide—derived from GM-CSF with six O-glycosylation sites and an N-terminal APARSPS epitope—and the in-house mAb CC1H7, which binds this epitope, in single or multiple copies, with enhanced affinity under high ionic strength. The mGMOP–mAb CC1H7 system was applied to immunoaffinity chromatography, Western blot, and competitive ELISA. Optimization used two engineered interferon variants: one with a single tag (mGMOP–IFN) and another with four tags (mGMOP3–IFN–mGMOP). A third variant, mGMOP3–EPO–mGMOP, was constructed using erythropoietin for further validation. Immunoaffinity purification was optimized via factorial design, testing different salts. The final protocol used 1 M Na₂SO₄ for loading and 50 mM sodium phosphate at pH 11 for elution, achieving 80–92 % recovery and 100 % purity. Competitive ELISA was optimized using a Box-Behnken design, yielding low LOD and LOQ. Western blotting confirmed detection of both IFN variants, also with low LOD and LOQ. All methods were successfully applied to tagged EPO. The platform enables standardized workflows for characterizing recombinant proteins without requiring protein-specific antibodies, and offers a versatile approach for protein bioprocessing.
{"title":"Innovative multifunctional tag system for protein purification and analytical characterization","authors":"María Jesús Leopold, Verónica Ferrando , Ricardo Kratje, Marcos Oggero, Natalia Ceaglio","doi":"10.1016/j.jchromb.2025.124811","DOIUrl":"10.1016/j.jchromb.2025.124811","url":null,"abstract":"<div><div>Epitope tag–monoclonal antibody (mAb) systems are essential tools in biotechnology. We developed a novel system based on the mGMOP peptide—derived from GM-CSF with six O-glycosylation sites and an N-terminal APARSPS epitope—and the in-house mAb CC1H7, which binds this epitope, in single or multiple copies, with enhanced affinity under high ionic strength. The mGMOP–mAb CC1H7 system was applied to immunoaffinity chromatography, Western blot, and competitive ELISA. Optimization used two engineered interferon variants: one with a single tag (mGMOP–IFN) and another with four tags (mGMOP3–IFN–mGMOP). A third variant, mGMOP3–EPO–mGMOP, was constructed using erythropoietin for further validation. Immunoaffinity purification was optimized via factorial design, testing different salts. The final protocol used 1 M Na₂SO₄ for loading and 50 mM sodium phosphate at pH 11 for elution, achieving 80–92 % recovery and 100 % purity. Competitive ELISA was optimized using a Box-Behnken design, yielding low LOD and LOQ. Western blotting confirmed detection of both IFN variants, also with low LOD and LOQ. All methods were successfully applied to tagged EPO. The platform enables standardized workflows for characterizing recombinant proteins without requiring protein-specific antibodies, and offers a versatile approach for protein bioprocessing.</div></div>","PeriodicalId":348,"journal":{"name":"Journal of Chromatography B","volume":"1267 ","pages":"Article 124811"},"PeriodicalIF":2.8,"publicationDate":"2025-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145294890","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-08DOI: 10.1016/j.jchromb.2025.124808
E. Lemaire , E. Gomez , D. Rosain , F. Courant
Fluoxetine, a widely prescribed antidepressant, is frequently detected in marine environments, exposing marine invertebrates to this emerging contaminant. Due to its potential to bioaccumulate and undergo biotransformation, it is essential to quantify both the parent compound and its metabolites for accurate risk assessment. Furthermore, tissue-specific measurements are crucial for identifying organ-specific accumulation that may cause localized toxic effects. An analytical method was then developed to quantify fluoxetine and three of its metabolites in individual mussel tissues (soft tissues, gills, digestive glands) using a minimal sample size (40 or 400 mg). Four solid-phase extraction sorbents were evaluated: MCX, HLB, C18, and Phree phospholipid removal. The Phree sorbent was selected as the optimal cleanup method. Further optimization involved testing two extraction solvents (acetonitrile and methanol) and two extraction techniques: ultrasonic-assisted extraction and bead-based extraction. Identification and quantification were performed using HPLC-Orbitrap-MS, relying on accurate mass measurements of selected MS/MS fragments. The method demonstrated satisfactory Method Quantification Limits (MQL) for fluoxetine (1.2, 10.5, and 10.4 μg/kg dw) and its main metabolite, norfluoxetine (5.1, 25.6, and 24.3 μg/kg dw) in soft tissues, digestive glands, and gills, respectively. These MQL values align with literature data, especially given the low sample size and the expression of concentrations on a dry weight basis. The final method allows the sensitive quantification of fluoxetine and its metabolites from small volumes, facilitating the assessment of their distribution across three target organs. These advancements support the development of toxicokinetic/toxicodynamic (TK/TD) models, contributing to environmental risk assessment of emerging contaminants.
{"title":"Accurate determination of fluoxetine and its metabolites in Mediterranean mussel organs based on solid phase extraction clean-up and HPLC-HRMS","authors":"E. Lemaire , E. Gomez , D. Rosain , F. Courant","doi":"10.1016/j.jchromb.2025.124808","DOIUrl":"10.1016/j.jchromb.2025.124808","url":null,"abstract":"<div><div>Fluoxetine, a widely prescribed antidepressant, is frequently detected in marine environments, exposing marine invertebrates to this emerging contaminant. Due to its potential to bioaccumulate and undergo biotransformation, it is essential to quantify both the parent compound and its metabolites for accurate risk assessment. Furthermore, tissue-specific measurements are crucial for identifying organ-specific accumulation that may cause localized toxic effects. An analytical method was then developed to quantify fluoxetine and three of its metabolites in individual mussel tissues (soft tissues, gills, digestive glands) using a minimal sample size (40 or 400 mg). Four solid-phase extraction sorbents were evaluated: MCX, HLB, C18, and Phree phospholipid removal. The Phree sorbent was selected as the optimal cleanup method. Further optimization involved testing two extraction solvents (acetonitrile and methanol) and two extraction techniques: ultrasonic-assisted extraction and bead-based extraction. Identification and quantification were performed using HPLC-Orbitrap-MS, relying on accurate mass measurements of selected MS/MS fragments. The method demonstrated satisfactory Method Quantification Limits (MQL) for fluoxetine (1.2, 10.5, and 10.4 μg/kg dw) and its main metabolite, norfluoxetine (5.1, 25.6, and 24.3 μg/kg dw) in soft tissues, digestive glands, and gills, respectively. These MQL values align with literature data, especially given the low sample size and the expression of concentrations on a dry weight basis. The final method allows the sensitive quantification of fluoxetine and its metabolites from small volumes, facilitating the assessment of their distribution across three target organs. These advancements support the development of toxicokinetic/toxicodynamic (TK/TD) models, contributing to environmental risk assessment of emerging contaminants.</div></div>","PeriodicalId":348,"journal":{"name":"Journal of Chromatography B","volume":"1267 ","pages":"Article 124808"},"PeriodicalIF":2.8,"publicationDate":"2025-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145262735","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-06DOI: 10.1016/j.jchromb.2025.124806
Karin Preindl , Thomas Stimpfl , Gunda Koellensperger , Fabian Dorninger , Johannes Berger , Christoph Wiesinger
Peroxisomes are subcellular compartments that host a variety of metabolic pathways, including the chain shortening of fatty acids (FAs) by beta-oxidation and certain steps in the formation of ether lipids. Here, we describe the development of a GC–MS/MS-based method for the simultaneous and reproducible determination of key metabolites of these pathways, also including less common FA species related to peroxisomal metabolism that are typically not part of standard analytical methods.
We for the first time utilize 1-chlorobutane for the extraction of FAs as an effective alternative to commonly used extraction solvents. 1-Chlorobutane offers a broader polarity range than hexane and lower toxicity relative to chloroform with solvent consumption of less than one mL per sample.
Six saturated long to very long-chain FAs, nine polyunsaturated FAs (PUFAs), two dicarboxylic FAs and 1-O-octadecyl glycerol (ODG, batyl alcohol) were extracted simultaneously. The method was validated using fibroblasts and for the majority of FA species accuracies ranged from 80 to 110 % with precision values (CV %) from 6 to 20 %. The measurement of ODG is for the first time described as marker for the estimation of the cellular ether lipid synthesis rate. The suitability of the method was demonstrated by the analysis of primary human fibroblasts from controls and individuals with peroxisomal disorders. This cell type represents a widely used model system for the investigation of peroxisomal metabolism and disease, thus rendering our protocol a valuable addition to the toolkit for studying peroxisomal pathways.
{"title":"A fast GC–MS/MS method for the simultaneous measurement of key metabolites of peroxisomal beta-oxidation and ether lipid biosynthesis in human fibroblasts","authors":"Karin Preindl , Thomas Stimpfl , Gunda Koellensperger , Fabian Dorninger , Johannes Berger , Christoph Wiesinger","doi":"10.1016/j.jchromb.2025.124806","DOIUrl":"10.1016/j.jchromb.2025.124806","url":null,"abstract":"<div><div>Peroxisomes are subcellular compartments that host a variety of metabolic pathways, including the chain shortening of fatty acids (FAs) by beta-oxidation and certain steps in the formation of ether lipids. Here, we describe the development of a GC–MS/MS-based method for the simultaneous and reproducible determination of key metabolites of these pathways, also including less common FA species related to peroxisomal metabolism that are typically not part of standard analytical methods.</div><div>We for the first time utilize 1-chlorobutane for the extraction of FAs as an effective alternative to commonly used extraction solvents. 1-Chlorobutane offers a broader polarity range than hexane and lower toxicity relative to chloroform with solvent consumption of less than one mL per sample.</div><div>Six saturated long to very long-chain FAs, nine polyunsaturated FAs (PUFAs), two dicarboxylic FAs and 1-O-octadecyl glycerol (ODG, batyl alcohol) were extracted simultaneously. The method was validated using fibroblasts and for the majority of FA species accuracies ranged from 80 to 110 % with precision values (CV %) from 6 to 20 %. The measurement of ODG is for the first time described as marker for the estimation of the cellular ether lipid synthesis rate. The suitability of the method was demonstrated by the analysis of primary human fibroblasts from controls and individuals with peroxisomal disorders. This cell type represents a widely used model system for the investigation of peroxisomal metabolism and disease, thus rendering our protocol a valuable addition to the toolkit for studying peroxisomal pathways.</div></div>","PeriodicalId":348,"journal":{"name":"Journal of Chromatography B","volume":"1267 ","pages":"Article 124806"},"PeriodicalIF":2.8,"publicationDate":"2025-10-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145262734","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-04DOI: 10.1016/j.jchromb.2025.124810
Ju Qu, Yifeng Li, Yan Wan
Protein L-based media are a type of affinity resin whose application in antibody purification is only secondary to Protein A resins. As Protein L resins exhibit stronger byproduct separation capabilities than Protein A resins, they are particularly preferred when purifying complex molecules such as bispecific antibodies (bsAbs). Despite the growing use of Protein L resins, comprehensive evaluations of their lifetime and cleaning-in-place (CIP) methods are generally lacking. In the current study, we examined MabSelect VL, Cytiva's second-generation Protein L resin, for its alkaline stability. In specific, the resin's performance was evaluated after 80 cycles of sanitization with 0.1 M sodium hydroxide (NaOH). In addition, the binding behavior of monomer and aggregates to aged resin was studied to understand the change in resin ligands during use. According to the data, 0.1 M NaOH is not well tolerated by MabSelect VL, and its repeated treatment causes performance degradation. Therefore, we recommend a milder sanitization method, 0.05 M NaOH, which can be combined with 1 % benzyl alcohol to improve microbial control.
蛋白l基介质是一种亲和树脂,其在抗体纯化中的应用仅次于蛋白a树脂。由于蛋白L树脂比蛋白A树脂具有更强的副产物分离能力,因此它们在纯化复杂分子(如双特异性抗体(bsab))时特别受欢迎。尽管蛋白L树脂的使用越来越多,但通常缺乏对其使用寿命和就地清洗(CIP)方法的全面评估。在目前的研究中,我们检测了MabSelect VL, Cytiva的第二代蛋白L树脂,其碱性稳定性。以0.1 M氢氧化钠(NaOH)消毒80次后,对树脂的性能进行了评价。此外,研究了单体和聚集体与老化树脂的结合行为,以了解树脂配体在使用过程中的变化。数据显示,MabSelect VL对0.1 M NaOH的耐受性不佳,反复处理会导致性能下降。因此,我们推荐一种较温和的消毒方法,0.05 M NaOH,可与1%苄醇结合使用,以改善微生物控制。
{"title":"Recommendation of a milder cleaning-in-place method for Cytiva's second-generation protein L resin MabSelect VL","authors":"Ju Qu, Yifeng Li, Yan Wan","doi":"10.1016/j.jchromb.2025.124810","DOIUrl":"10.1016/j.jchromb.2025.124810","url":null,"abstract":"<div><div>Protein L-based media are a type of affinity resin whose application in antibody purification is only secondary to Protein A resins. As Protein L resins exhibit stronger byproduct separation capabilities than Protein A resins, they are particularly preferred when purifying complex molecules such as bispecific antibodies (bsAbs). Despite the growing use of Protein L resins, comprehensive evaluations of their lifetime and cleaning-in-place (CIP) methods are generally lacking. In the current study, we examined MabSelect VL, Cytiva's second-generation Protein L resin, for its alkaline stability. In specific, the resin's performance was evaluated after 80 cycles of sanitization with 0.1 M sodium hydroxide (NaOH). In addition, the binding behavior of monomer and aggregates to aged resin was studied to understand the change in resin ligands during use. According to the data, 0.1 M NaOH is not well tolerated by MabSelect VL, and its repeated treatment causes performance degradation. Therefore, we recommend a milder sanitization method, 0.05 M NaOH, which can be combined with 1 % benzyl alcohol to improve microbial control.</div></div>","PeriodicalId":348,"journal":{"name":"Journal of Chromatography B","volume":"1267 ","pages":"Article 124810"},"PeriodicalIF":2.8,"publicationDate":"2025-10-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145254446","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}